Literature DB >> 22567427

Clinical profile and outcome of conservatively managed emphysematous pyelonephritis.

Praveen Kumar Kolla1, Desai Madhav, Satish Reddy, Suneetha Pentyala, Panil Kumar, Rama Mohan Pathapati.   

Abstract

Emphysematous pyelonephritis (EPN) is a severe, necrotizing renal parenchymal infection characterized by production of intraparenchymal gas. EPN predominantly affects female diabetics and immunocompromised patients. In a three-year period 2008-2011, a total of 8 patients were admitted to our hospital. All of them were diabetics, and both males and females were equally affected. These patients showed vague symptoms at admission and frequently presented with fever, loin pain, dysuria, and pyuria necessitating urgent medical attention. EPN required radiological diagnosis. CT scan revealed bilateral EPN with urinary obstruction and hydronephrosis in 50% of patients. Escherichia coli was found to be the causative organism in all the patients. Treatment comprised of resuscitation, normalization of serum electrolytes and blood sugars, administration of parenteral antibiotics, and relieving ureteric obstruction if present. All the patients improved with conservative management without any mortality.

Entities:  

Year:  2012        PMID: 22567427      PMCID: PMC3329657          DOI: 10.5402/2012/931982

Source DB:  PubMed          Journal:  ISRN Urol        ISSN: 2090-5807


1. Introduction

Emphysematous pyelonephritis (EPN) is a life-threatening, fulminant, necrotizing upper urinary tract infection associated with gas within the kidney and/or perinephric space [1]. We present the clinical profiles and outcome of eight patients with EPN who were managed conservatively without any mortality.

2. Methods

During the period 2008–2011, a total of eight diabetic patients with clinical features of EPN and computerized tomography (CT) image showing gas in renal parenchyma, collecting system or perirenal space, and no fistulous connection between urinary tract and bowel were evaluated.

3. Results

All the patients were between 33 and 58 yrs. Males and females were equal in numbers. Clinical profiles and outcomes were shown in Table 1. All of them presented with fever, loin pain, dysuria, and oliguria. At admission, renal dysfunction was observed in all these patients with a mean serum creatinine of 5.47 ± 2.3 (2.3–7.8) mg/dL. Most of them had poorly controlled blood sugar levels (seven out of eight). Escherichia coli was found to be the causative organism in all the patients as per urine culture. CT imaging showed bilateral involvement in four (Huang et al. staging class IV) and unilateral in 4 (Classes I, II and III). Hydronephrosis was seen in fifty percent of patients (three unilateral and one bilateral). There were air pockets in the perinephric collection, proximal ureter, and in the urinary bladder of two patients (Figures 1, 2, 3, and 4). Five patients required renal replacement therapy for severe renal failure. DJ stenting was done in 4 patients for obstructed urinary system. None of them required any other surgical intervention. All patients were discharged in a stable condition with a mean serum creatinine of 2.40 ± 0.76 (1.6–3.3) mg/dL.
Table 1

Clinical profile and outcome of patients with EPN.

Patient12345678
Gender/age (yr)M/54F/52M/33F/53F/55M/58M/38F/54
Duration of diabetes (yr)18104581256
Fever++++++++
Loin pain++++++++
Oliguria++++++
Dysuria++++++++
Serum creatinine at admission (mg/dL)77.72.37.82.75.83.17.4
Serum creatinine at discharge (mg/dL)3.33.241.82.61.61.71.83.2
Urine culture E. coli E. coli E. coli E. coli E. coli E. coli E. coli E. coli
Blood cultureSterileSterileSterileSterileSterileSterileSterileSterile
LateralityBilateralBilateralUnilateralBilateralUnilateralBilateralUnilateralUnilateral
Huang et al. CT-scan staging443A41422
Hemodialysis sessions44030404
HydronephrosisYesNoNoYesNoYesNoYes
DJ stentYesNoNoYesNoYesNoYes
Duration of DJ stent (days)10141412
Recurrence of obstructionNoNoNoNo
Antibiotics usedIMEIMEIMEPip + TzCef + SlbIMECef + SlbIME
Duration of antibiotics (days)1014101414101410

IME: Imipenem, Pip + Tz: Piperacillin + Tazobactam, Cef + Slb: Cefoperazone + Sulbactam.

Figure 1

(a) CT KUB showing bilateral emphysematous pyelonephritis (Class IV). (b) CT KUB showing resolution of air pockets after 10 days of treatment.

Figure 2

(a) CT KUB showing air pockets in right collecting system. (b) CT KUB showing air pocket in right proximal ureter.

Figure 3

CT KUB showing air pocket in left renal parenchyma and perinephric collection.

Figure 4

CT KUB showing emphysematous cystitis.

4. Discussion

EPN is defined as a severe necrotizing renal parenchymal infection that is characterized by the bacterial production of gas within the renal parenchyma. The commonest causative organism is Escherichia coli, followed by Proteus, Klebsiella, anaerobic Streptococci, and Candida. EPN is common in females, diabetics [1], and immune-compromised patients [2]. EPN has been reported in renal transplant recipients [3-6] and in patients with polycystic kidney disease [7, 8]. The diagnosis of EPN is often delayed because the appearances of symptoms are very hazy and nonspecific. Common presentation includes fever, abdominal pain, dysuria, vomiting, depressed level of consciousness, shock, renal angle tenderness, and acute kidney injury [9]. Less common presentation includes dyspnea, crepitus over the flanks, and pneumaturia [10]. In our study, all the patients were diabetics, and majority had uncontrolled blood sugars. All of them presented with fever, loin pain, dysuria, pyuria, and oliguria. Dyspnea and pedal edema are seen in 5/8, and one had altered sensorium. The causative organism was found to be Escherichia coli in urine cultures in all the patients. None of the patients had mixed infections. EPN requires a radiological diagnosis and CT being the definitive modality for diagnosis [11]. CT imaging [12] not only reveals the presence and position of gas in the renal parenchyma but also is useful to assess the extent of renal parenchymal involvement and response to therapy. Abdominal ultrasonography (USG) and X-ray can also be used to diagnose EPN. In our study, ultrasonography gave a clue for the presence of gas in renal parenchyma in five patients. CT showed the presence of EPN, even in those situations where USG could not pick up. Urinary obstruction and hydronephrosis was noted in 50% of patients. It is possible that urinary tract obstruction and decreased renal vascular supply due to diabetes might have contributed for the development of EPN in our patients. Patients with emphysematous pyelonephritis (EPN) should be treated with aggressive medical management and possibly prompt surgical intervention [1, 13, 14]. Active management with appropriate parenteral antibiotics, addressing the fluid-electrolyte and hemodynamic status, stringent control of diabetes with insulin, and relieving ureteric obstruction either by percutaneous drainage or internal stenting has improved the clinical outcome of our patients without any mortality. None of them required any major surgical intervention, even though more than half of the patients were in class 3 and class 4 EPN and having more than two risk factors such as elevated serum creatinine, altered sensorium, and shock. Recent case reports have also described successful outcome in patients with bilateral EPN with medical therapy alone [15, 16]. At discharge, all the patients had elevated serum creatinine; time to normalization of renal parameters could not be assessed as most of these patients were lost for followup.

5. Conclusions

Emphysematous pyelonephritis is not uncommon. It should be suspected in every diabetic patient with urosepsis. CT is the definitive modality for diagnosing EPN. Early diagnosis and effective conservative treatment obviate the need for nephrectomy and decrease mortality.
  15 in total

1.  Emphysematous pyelitis: findings in five patients.

Authors:  C Roy; D D Pfleger; C M Tuchmann; H H Lang; C C Saussine; D Jacqmin
Journal:  Radiology       Date:  2001-03       Impact factor: 11.105

2.  A case of emphysematous pyelonephritis in a renal allograft.

Authors:  Seiji Arai; Takeaki Makino; Hironobu Okugi; Masaru Hasumi; Yasuhiro Shibata; Motoaki Hatori; Kazuhiro Suzuki
Journal:  Transplantation       Date:  2006-01-27       Impact factor: 4.939

3.  Percutaneous drainage in the treatment of emphysematous pyelonephritis: 10-year experience.

Authors:  M T Chen; C N Huang; Y H Chou; C H Huang; C P Chiang; G C Liu
Journal:  J Urol       Date:  1997-05       Impact factor: 7.450

4.  Emphysematous pyelonephritis: clinicoradiological classification, management, prognosis, and pathogenesis.

Authors:  J J Huang; C C Tseng
Journal:  Arch Intern Med       Date:  2000-03-27

Review 5.  Emphysematous pyelonephritis.

Authors:  J Michaeli; P Mogle; S Perlberg; S Heiman; M Caine
Journal:  J Urol       Date:  1984-02       Impact factor: 7.450

6.  Bilateral emphysematous pyelonephritis and emphysematous cystitis with autosomal-dominant polycystic kidney disease: is conservative management justified?

Authors:  Narayanaswamy Arun; Abdullatif Hussain; Madan Mohan Kapoor; Fawzi Abul
Journal:  Med Princ Pract       Date:  2007       Impact factor: 1.927

7.  Successful medical treatment of emphysematous pyelonephritis in a renal allograft recipient.

Authors:  K V Baliga; A S Narula; A Sharma; R Khanduja; M Manrai; J Debnath; A S Sandhu
Journal:  Ren Fail       Date:  2007       Impact factor: 2.606

8.  Emphysematous pyelonephritis in dialysis patient after embolization of failed allograft.

Authors:  Alberto Ortiz; Vladimir Petkov; Jose Urbano; Julio Contreras; Simona Alexandru; Alicia Garcia-Pérez; Ana Ramos; Jesus M Cabrera; Marta Albalate; Juan V Garcia-Cardoso
Journal:  Urology       Date:  2007-08       Impact factor: 2.649

Review 9.  Severe emphysematous pyelonephritis in a renal allograft: successful treatment with percutaneous drainage and antibiotics.

Authors:  Y W Chuang; C H Chen; C H Cheng; S W Hung; T M Yu; M J Wu; K H Shu
Journal:  Clin Nephrol       Date:  2007-07       Impact factor: 0.975

Review 10.  Acute bilateral emphysematous pyelonephritis successfully managed by medical therapy alone: a case report and review of the literature.

Authors:  Guillermo Flores; Haiko Nellen; Francisco Magaña; Juan Calleja
Journal:  BMC Nephrol       Date:  2002-06-03       Impact factor: 2.388

View more
  10 in total

1.  Coexistence of emphysematous cystitis and bilateral emphysematous pyelonephritis: a case report and review of the literature.

Authors:  Venice Chávez-Valencia; Citlalli Orizaga-de-La-Cruz; Omar Aguilar-Bixano; Francisco Alejandro Lagunas-Rangel
Journal:  CEN Case Rep       Date:  2020-04-23

2.  Neutrophil:Lymphocyte Ratio as a Predictive Factor for Success of Nephron-Sparing Procedures in Patients with Emphysematous Pyelonephritis.

Authors:  Chirag Punatar; Kunal Jadhav; Vikash Kumar; Vinod Joshi; Sharad Sagade
Journal:  Perm J       Date:  2019

3.  Emphysematous pyelonephritis: Six case reports and review of literature.

Authors:  Li-Ping Ma; Ning Zhou; Yan Fu; Yan Liu; Cong Wang; Bin Zhao
Journal:  World J Clin Cases       Date:  2022-04-06       Impact factor: 1.534

4.  Case of emphysematous pyelonephritis in kidney allograft: Conservative treatment.

Authors:  Antonio Tienza; Mateo Hevia; Imanol Merino; Jose Maria Velis; Ruben Algarra; Juan Ignacio Pascual; Juan Javier Zudaire; Jose Enrique Robles
Journal:  Can Urol Assoc J       Date:  2014-03       Impact factor: 1.862

5.  Emphysematous pyelonephritis: Is nephrectomy warranted?

Authors:  Mada Alsharif; Abdullah Mohammedkhalil; Basim Alsaywid; Ali Alhazmy; Salahadin Lamy
Journal:  Urol Ann       Date:  2015 Oct-Dec

Review 6.  Emphysematous pyelonephritis: Time for a management plan with an evidence-based approach.

Authors:  Omar M Aboumarzouk; Owen Hughes; Krishna Narahari; Richard Coulthard; Howard Kynaston; Piotr Chlosta; Bhaskar Somani
Journal:  Arab J Urol       Date:  2013-11-19

7.  Emphysematous pyelonephritis: the impact of urolithiasis on disease severity.

Authors:  Thomas H Sanford; Frank Myers; Thomas Chi; Herman S Bagga; Andrew G Taylor; Marshall L Stoller
Journal:  Transl Androl Urol       Date:  2016-10

8.  A rare occurrence of hepatic portal venous gas in emphysematous pyelonephritis.

Authors:  Debraj Sen; Arjun S Sandhu
Journal:  Indian J Urol       Date:  2014-01

9.  Clinical profile and successful outcomes of conservative and minimally invasive treatment of emphysematous pyelonephritis.

Authors:  Vilvapathy Senguttuvan Karthikeyan; Chikka Moga Siddaiah Manohar; Ashwin Mallya; Ramaiah Keshavamurthy; Anant Janardhan Kamath
Journal:  Cent European J Urol       Date:  2018-04-16

10.  Clinical Practice Guidelines for the Antibiotic Treatment of Community-Acquired Urinary Tract Infections.

Authors:  Cheol In Kang; Jieun Kim; Dae Won Park; Baek Nam Kim; U Syn Ha; Seung Ju Lee; Jeong Kyun Yeo; Seung Ki Min; Heeyoung Lee; Seong Heon Wie
Journal:  Infect Chemother       Date:  2018-03
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.